Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2851 AL 2865

The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders

Wójtowicz S, Strosznajder AK, Jeżyna M, Strosznajder JB.

Neurochem Res. 2020 May;45(5):972-988. doi: 10.1007/s11064-020-02993-5. Epub 2020 Mar 13.

Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: A case report

Li HC, Luo KX, Wang JS, Wang QX.

Medicine (Baltimore). 2020 Mar;99(11):e19443. doi: 10.1097/MD.0000000000019443.

Synaptic Activity and (Neuro)Inflammation in Alzheimer's Disease: Could Exosomes be an Additional Link?

Counil H, Krantic S.

J Alzheimers Dis. 2020;74(4):1029-1043. doi: 10.3233/JAD-191237.

In silico Exploration of Bioactive Phytochemicals Against Neurodegenerative Diseases Via Inhibition of Cholinesterases

Mahomoodally F, Abdallah HH, Suroowan S, Jugreet S, Zhang Y, Hu X.

Curr Pharm Des. 2020;26(33):4151-4162. doi: 10.2174/1381612826666200316125517.

A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain

Li S, Selkoe DJ.

J Neurochem. 2020 Sep;154(6):583-597. doi: 10.1111/jnc.15007. Epub 2020 Apr 5.

Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements

Tadokoro K, Ohta Y, Inufusa H, Loon AFN, Abe K.

Int J Mol Sci. 2020 Mar 13;21(6):1974. doi: 10.3390/ijms21061974.

[Pharmacological prevention of cognitive decline and dementia]

Jessen F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):506-511. doi: 10.1007/s00103-020-03120-z.

The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease

Servizi S, Corrigan RR, Casadesus G.

Curr Pharm Des. 2020;26(12):1345-1355. doi: 10.2174/1381612826666200318151146.

Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer's Disease

Gião T, Saavedra J, Cotrina E, Quintana J, Llop J, Arsequell G, Cardoso I.

Int J Mol Sci. 2020 Mar 18;21(6):2075. doi: 10.3390/ijms21062075.

Olesoxime improves cerebral mitochondrial dysfunction and enhances Aβ levels in preclinical models of Alzheimer's disease

Eckert GP, Eckert SH, Eckmann J, Hagl S, Muller WE, Friedland K.

Exp Neurol. 2020 Jul;329:113286. doi: 10.1016/j.expneurol.2020.113286. Epub 2020 Mar 18.

Synchronous measuring of triptolide changes in rat brain and blood and its application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats

Zhu S, Wang X, Zheng Z, Zhao XE, Bai Y, Liu H.

J Pharm Biomed Anal. 2020 Jun 5;185:113263. doi: 10.1016/j.jpba.2020.113263. Epub 2020 Mar 17.

Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F)

Li L, Kim HJ, Roh JH, Kim M, Koh W, Kim Y, Heo H, Chung J, Nakanishi M, Yoon T, Hong CP, Seo SW, Na DL, Song J.

Cell Prolif. 2020 Apr;53(4):e12798. doi: 10.1111/cpr.12798. Epub 2020 Mar 25.

The β-Secretase BACE1 in Alzheimer's Disease

Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, Zhou J, Yan R, Vanmechelen E, De Vos A, Nisticò R, Corbo M, Imbimbo BP, Streffer J, Voytyuk I, Timmers M, Tahami Monfared AA, Irizarry M, Albala B, Koyama A, Watanabe N, Kimura T, Yarenis L, Lista S, Kramer L, Vergallo A.

Biol Psychiatry. 2021 Apr 15;89(8):745-756. doi: 10.1016/j.biopsych.2020.02.001. Epub 2020 Feb 13.

Melatonin effects on EEG activity during non-rapid eye movement sleep in mild-to-moderate Alzheimer´s disease: a pilot study

Cruz-Aguilar MA, Ramírez-Salado I, Hernández-González M, Guevara MA, Del Río JM.

Int J Neurosci. 2021 Jun;131(6):580-590. doi: 10.1080/00207454.2020.1750392. Epub 2020 Apr 13.

Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease

Arora D, Bhatt S, Kumar M, Vattikonda HDC, Taneja Y, Jain V, Joshi V, Gali CC.

Curr Pharm Des. 2020;26(27):3281-3299. doi: 10.2174/1381612826666200331085854.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias